New CMS Projections on Medicare Spending Warrant Scrutiny
According to a federal report issued yesterday by the Centers for Medicare and Medicaid Services (CMS), government is expected to cover
State of the Union Should Include Older Americans’ Priorities
Seniors struggling with soaring health care and prescription drug costs deserve re-assurance that the White House is actually on their side. The
Hill Democrats Get Tough on Big Pharma, Prescription Drug Prices
Elections have consequences, and one positive consequence of the midterms is that the new House majority is serious about reducing drug
New Alzheimer’s Funding is a Good Start, but ‘BOLDer’ Action is Needed
In the waning hours of 2018, President Trump signed into law a bipartisan bill to boost federal efforts to address
New Acting White House Chief of Staff No Friend to Seniors
New Acting White House Chief of Staff Mick Mulvaney (photo credit: Gage Skidmore) It’s unfortunate that in a desperate
Trump Administration Continues Tilting the Field toward Medicare Advantage
During the Medicare open enrollment period that ends today, the Trump administration once again asked beneficiaries to choose plans without the
Trump Administration Drug Proposal Puts Burden on Beneficiaries
Instead of taking big, bold steps to lower prescription drug prices, the Trump administration has rolled out yet another incremental measure that
National Committee President Campaigns for Mike Espy
National Committee president Max Richtman stumped for Senate candidate Mike Espy in Tupelo, Mississippi yesterday. Democrat Espy faces GOP incumbent Cindy
Seniors Were Big Winners in House Elections
Voters have put champions of Social Security and Medicare back in control of the U.S. House of Representatives for the first
Don’t be Fooled by GOP Posturing on Pre-Existing Conditions
The Republican candidate for the open Senate seat in Arizona, Martha McSally, probably speaks for other GOP contenders across the country